Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 UC Davis Researcher Presents UC-II Joint Health Research - Nutraceuticals World
Research

UC Davis Researcher Presents UC-II Joint Health Research

Siba Raychaudhuri, MD, UC Davis researcher, presented a portfolio of joint-health research on UC-II, including published clinical data, at the Federation of Clinical Immunology Societies (FOCIS) 2010 meeting in June. Dr. Raychaudhuri is also the corresponding author of a published clinical study demonstrating that UC-II, from InterHealth Nutraceuticals, was more than twice as effective as glucosamine + chondroitin. The presentation was titled, “Undenatured Type II Collagen (UC-II) in the Treatment of Osteoarthritis.”

“Not only is the clinical data on UC-II impressive, it also works in quite a unique way to inhibit joint cartilage damage, allowing the body to rebuild healthy joints,” said Dr. Raychaudhuri. “UC-II contains undentaured type II collagen, which reportedly aids in reducing the destruction of collagen within the joints, helps to reduce inflammation in the joints and improves joint flexibility.”

UC-II brand undenatured type II collagen is derived from chicken sternum cartilage for joint health by patented, low-temperature, non-enzymatic manufacturing processes that ensure the presence of active epitopes—giving UC-II its unique mechanism of action and increased clinical efficacy. For further information: www.interhealthusa.com

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters